First 3DHEALS healthcare 3D printing and bioprinting event in Cleveland. We will have a panel of experts from clinical and startup worlds to speak about their field of expertise. Stay tuned for agenda and speaker info soon. More info can be found on 3d-heals.com website.
Team NEO Offices
1111 Superior Ave 4th Floor Conference Room
Cleveland, Ohio 44114
This event is organized by Cleveland 3DHEALS Community Manager Dr. Justin Baker.
Dr. Justin Baker graduated magna cum laude and with university honors in mechanical engineering from Brigham Young University (BYU). Dr. Baker subsequently earned his PhD in Bioengineering from the University of Utah. A postdoctoral fellowship at the Cleveland Clinic brought him and his family to Cleveland in 2010. Since then Dr. Baker has worked for a number of local start-up and mid-size medical device companies. Dr. Baker has worked the last 4 years in the Regenerative Medicine and advanced wound care field. In 2014, Dr. Baker was certified in Regulatory Affairs (RAC). He currently serves as the Vice President of Research & Development for Viscus Biologics, a Cleveland medical device design and manufacturing company focused on form-factoring natural polymers.
Greg Cebular is the VP of Sales & Project Management at The Technology House (TTH). The Technology House is a Contract Manufacturer specializing in Additive Manufacturing, Cast Urethane Molding, Injection Molding and CNC Machining. With its sister company, Sea Air Space Machining & Molding, TTH produces prototypes and production parts to all major industries but a majority comes from Medical with ISO 13485 and Aerospace with ISO AS9100D certification production.
Greg started in 3D printing with TTH 2003 after studying at Ohio University. At TTH, Greg’s team of project managers work hand in hand with customers to help educate, design, develop, prototype and ultimately produce production parts based on the best material and process to meet the customer’s requirements.
Jan Jensen, PhD, CEO/CSO, Founder of Trailhead Biosystems. Jan is the Lead Inventor of Trailhead Technology and has 20 years as molecular developmental biologist. He is the Eddie J. Brandon Endowed chair of Diabetes Research at the Cleveland Clinic. He obtained his PhD from U. Copenhagen in 1998, and has been faculty at US institutions since 2001. Jan has published more than 50 peer reviewed papers, and is now engaged with multiple research projects and consortia covering neural, renal, pancreatic areas, as well as cancer and immunotherapy. The technology of Trailhead Biosystems is high dimensional design of experiments, which rests on computerized designs and robotic executions. Jan’s vision is to see systems biology become adopted and he aspires to industrialize the manufacture of specialized human cells forregenerative medicine.
Jacob Eva is a Cleveland native. He earned a BS in Advanced Manufacturing from Ohio Northern University. Since college Jake has worked in 3D printing and prototyping for a number companies holding roles in sales and marketing as well as managing 7 SLA machines that ran 24/7. Jake joined Custom Orthopaedic solutions (COS), a Cleveland Clinic sponsored company in 2014. In 2018, COS sold their shoulder product line to Arthrex. COS is currently awaiting FDA clearance for their patient specific airway stenting system.
Brian L. Davis, Ph.D. is the chair of Mechanical Engineering at Cleveland State University. Prior to joining CSU this year, he was a Professor of Biomedical Engineering at The University of Akron, serving as Chair from 2012 to 2018. In addition, he was formerly Vice Chair of the Department of Biomedical Engineering at The Cleveland Clinic Foundation, and Director of the Medical Device Solutions team. He played a key role in developing a partnership between the Cleveland Clinic and Parker Hannifin Corporation. Similarly, he served as co-Director of the joint Cleveland Clinic/CSU program in Applied Biomedical Engineering. In terms of medical devices, Davis has led a number of initiatives focused on rehabilitation technology and instrumentation for assessing a patient’s risk for diabetic foot ulceration. More recently he has received funding from the National Science Foundation for initiatives related to STEM outreach to under-represented students.
Thanks to our sponsors: